Test Bank For Mosbys Pharmacy Technician 3rd Edition by Teresa Hopper
Hopper: Mosby’s Pharmacy Technician, 3rd Edition
Chapter 2: Pharmacy Federal Laws and Regulations
TRUE/FALSE
1. The definition of confidentiality is to keep privileged information about a customer from being disclosed without his or her consent.
ANS: T
The definition of confidentiality is to keep privileged information about a customer from being disclosed without his or her consent.
PTS: 1 DIF: 1 (Knowledge) REF: p. 33
NAT: Module 15 IO 29.1.2 (Comprehension) Explain patient confidentiality issues related to data collection, transmission, and storage by pharmacy information systems and by electronic medical records. | IO 29.1.1 (Comprehension) Explain situations in which the pharmacy | technician must be aware and observant of the confidentiality of | patient information.
2.There are no safeguards to protect patient information via the computer.
ANS: F
There are several safeguards in place that help to protect electronically transmitted patient information.
PTS: 1 DIF: 1 (Knowledge) REF: p. 33
NAT: Module 15 IO 29.1.2 (Comprehension) Explain patient confidentiality issues related to data collection, transmission, and storage by pharmacy information systems and by electronic medical records. | IO 29.1.1 (Comprehension) Explain situations in which the pharmacy | technician must be aware and observant of the confidentiality of | patient information.
3. Having corrections added to your health information is a right of the patient.
ANS: T
Have corrections been added to your health information?
PTS: 1 DIF: 1 (Knowledge) REF: p. 34
NAT: Module 15 | OBJ 21.2 (Comprehension) Explain some typical adaptations made indirect patient care plans to accommodate diversity.
4.As a technician you may provide a patient’s personal or medical information to anyone who is a member of your family.
ANS: F
According to HIPAA the pharmacy technician cannot do the following:
• Provide any personal or medical information pertaining to the patient to any entity not covered under HIPAA rules and regulations.
• Share any information with any family member or friend, co-worker, manager, or any entity not covered under HIPAA rules and regulations.
PTS: 1 DIF: 1 (Knowledge) REF: p. 34
NAT: Module 15 IO 29.1.2 (Comprehension) Explain patient confidentiality issues related to data collection, transmission, and storage by pharmacy information systems and by electronic medical records. | IO 29.1.1 (Comprehension) Explain situations in which the pharmacy | technician must be aware and observant of the confidentiality of | patient information.
5.The Drug Addiction Treatment Act prohibits physicians from prescribing controlled substances.
ANS: F
The Drug Addiction Treatment Act of 2000 permits physicians to prescribe controlled substances (preapproved by the DEA) in schedules C-III, C-IV, or C-V to persons suffering from opioid addiction, for the purpose of maintenance or detoxification treatments.
PTS: 1 DIF: 1 (Knowledge) REF: p. 36
NAT: Module 25 | OBJ 15.2 (Comprehension) Explain the programs currently in place for reporting medication misadventures on a global and institutional level.
6.Medicare has a long history, starting in 1965.
ANS: T
Medicare has had a long history, starting in 1965.
PTS: 1 DIF: 1 (Knowledge) REF: p. 36
NAT: [none]
7.Until 2000 the drug pseudoephedrine was sold OTC as a decongestant and was not limited in quantity for purchase by the consumer.
ANS: F
Until 2004 the drug pseudoephedrine was sold OTC as a decongestant and was not limited in quantity for purchase by the consumer.
PTS: 1 DIF: 1 (Knowledge) REF: p. 36
NAT: [none]
8.Two government agencies that are important with respect to pharmacy are the FDA and DEA.
ANS: T
Two government agencies that are important with respect to pharmacy are the FDA and DEA.
PTS: 1 DIF: 1 (Knowledge) REF: p. 38
NAT: [none]
9.In 1972 the Drug Listing Act was implemented under the authority of the DEA.
ANS: F
In 1972 the Drug Listing Act was implemented under the authority of the FDA.
PTS: 1 DIF: 1 (Knowledge) REF: p. 38
NAT: [none]
10.Opioids are stimulants that have no addictive potential.
ANS: F
Controlled substances such as barbiturates, opioids, benzodiazepines, and central nervous system stimulants are substances that are addictive and have a potential to be abused.
PTS: 1 DIF: 1 (Knowledge) REF: p. 41
NAT: Module 2 | IO 34.5.3 (Comprehension) Explain the therapeutic effects of prescription medications, nonprescription medications, and alternative therapies commonly used to treat diseases of the nervous system.
Reviews
There are no reviews yet.